Kuopio University Hospital
Kuopio, Northern Savonia, 70029, Finland
NCT Number: NCT02642731
Sensitive renal markers have been studied abundantly in connection with open heart, liver and transplantation surgery; however in major orthopaedic surgery their use is anecdotal. The aim of the present study is to evaluate use of sensitive renal markers, NGAL (Neutrophil gelatinase associated lipocalin ), KIM-1 (Kidney injury molecule- 1), LFABP (liver-type fatty acid-binding protein), and IL-18 (interleukin -18), in patients coming for elective TKA (total knee arthroplasty) as a pilot study before large study concerning acute kidney injury in orthopaedic surgery.
Looking for future studies?
Notify Me50 year–75 year
All sexes
Observational
Kuopio, Northern Savonia, 70029, Finland
Acute renal deterioration is a serious adverse event in elective surgery. Serum creatinine based diagnostics of acute kidney injury may delay diagnosis and produce false negative results since serum creatinine is affected by diet, muscle mass, used hydration therapy. In recent times new markers have been developed and tested in order to find sensitive, fast and reliable marker of renal deterioration.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: time zero hours to 48 hours
S-creatinine, Cystatin C, estimated GFR
Time frame: time zero hours to 24 hours
U-NGAL, P-NGAL, U-KIM-1, U-IL-18
Kuopio University Hospital
Other
Kidney Biomarkers of Acute Kidney Injury in Patients With Knee Arthroplasty- a Pilot Study
Acronym: dexpolvi
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03795805
Acute Kidney Injury, Arthritis
Mexico City, Mexico
View Trial DetailsNCT04828083
Arthroplasty, Replacement, Knee, Total Knee Arthroplasty
Providence, Rhode Island, United States
View Trial DetailsNCT03965897
Anxiety, Anxiety Disorders
Iowa City, Iowa, United States
View Trial DetailsNCT07231692
Arthroplasty, Replacement, Knee, Neurologic Manifestations
Karabük, Karabük Province, Turkey (Türkiye)
View Trial Details